Capital Protection Certificate Pharma-Aktien Bond 106 % The product related information contained herein is exclusively for information purposes only, intended for current investors or in case these products are displayed further to an individual search. The information does not constitute a recommendation or an offer to buy or an invitation to make a respective offer in relation to any of the products described herein.
Change+0.690 (+0.72%) Bid95.87% Ask97.37% Last updateNov 22, 2024
18:59:59.583
UTC
Name
Pharma-Aktien Bond 106 %
ISIN / WKN
AT0000A3EK46 / RC1E84
Underlying
Capital protection amount
106%
Participation factor
-
Cap
-
Underlying price
-
Starting value
EUR 100.00
Strike
EUR 106.00
Denomination / nominal
EUR 1,000
About the term
Initial valuation date
Oct 18, 2024
Issue date
Oct 21, 2024
Final valuation date
Oct 16, 2030
Maturity date
Oct 21, 2030
Product classification
Investment Product with Capital Protection
Security type (eusipa Nr.)
Capital Protection Certificate (1140)
Capital Protection Certificate Type
coupon orientated
Underlying
Country / region of underlying
-
Suited market expectation
bullish
Starting value
EUR 100.00
Strike
EUR 106.00
Cap
-
Issue price
100.00%
Spread homogenised
1.50
Spread in %
1.56%
Multiplier
-
Product currency
EUR
Underlying currency
-
Settlement method
Cash settlement
Tax treatment
Capital Gains Tax / No EU Withholding Tax
Public offer in
Austria, Germany, Italy, Hungary, Poland, Czech Republic, Slovakia, Bulgaria, Croatia, Liechtenstein, Romania, Slovenia
Listing
Vienna, Stuttgart
Comments

The certificate Pharma Stocks Bond 106% offers a capital protection of 106% at the end of term. In addition, there is the opportunity to receive an interest payment of 7.5% each year. This interest rate is paid out if all 3 underlying shares quote at or above their starting value on the annual valuation date. If this is not the case, no interest rate is paid out for the corresponding year.